As with many skin conditions, TSW can manifest differently with different skin colours. On white skin it glows an intense red, but on black or brown skin it can appear as deep purple, brown, or with a greyish tinge, which often makes it even harder to spot and diagnose.
Around 16,000 fans packed into the Manchester arena bought into the Itauma buzz, greeting him with a warm roar as he was walked to the ring by British rapper Meekz.
Itauma – the prodigy who was sparring seasoned professionals while still at school – was in wonderful form from the first bell, using his speed and variation to send Franklin backtracking.
In truth, the knockout felt inevitable even when 32-year-old Franklin managed to recover from a third-round right hand that sent him crashing to the floor.
Working behind a jab and picking his shots wisely, Itauma avoided anything reckless. “It’s a breakdown job,” trainer Ben Davison aptly told him between rounds.
This was another night that thrilled and told us a little more about the rising heavyweight.
Itauma’s devastating power is undeniable, once again on display as he dispatched a seasoned opponent inside the first half of the fight.
But the bigger questions remain.
His chin has yet to be properly tested. Franklin landed a right in the fourth, and Itauma just smiled, but he will face bigger punches in the future.
And while the knockouts keep coming, he is still unproven beyond six rounds, with his engine and endurance untested at the highest level.
Promoter Warren expects Itauma to fight for a world title this year.
Within boxing circles, that talk may be slightly premature but Itauma is keeping pace with two-time world champion Anthony Joshua.
At the same stage of his career, Joshua beat Gary Cornish to register a 14th stoppage and was selling out the O2 Arena. Itauma is on a similar trajectory, almost filling the Co-op Live Arena – and arguably facing higher-level opponents along the way.
The key step-up for Joshua came in his 15th fight: a win over Dillian Whyte for the British title, which developed his resolve and enhanced his profile.
By his 17th, he was world champion after defeating Charles Martin.
For the second year in a row, United States Vice President JD Vance has topped the straw poll at the 2026 Conservative Political Action Conference (CPAC), one of the biggest right-wing gatherings in the country.
The poll is a bellwether – albeit, not necessarily an accurate one – for who might ultimately become the Republican nominee for the next presidential race.
list of 3 itemsend of list
During this year’s four-day conference, attendees were asked which candidate they would prefer at the top of the Republican Party ticket for the 2028 election.
The results were revealed on stage Saturday. Vance had swept up 53 percent of the votes cast by nearly 1,600 attendees.
But rising up the ranks was another senior official under US President Donald Trump: his top diplomat, Secretary of State Marco Rubio. A former senator from Florida, Rubio notched 35 percent of the vote.
It was a markedly improved standing for Rubio, who tied for fourth place at last year’s CPAC straw poll.
That poll, taken within weeks of Trump starting his second term, showed Vance with 61 percent support, former Trump adviser Steve Bannon with 12 percent, and Florida Governor Ron DeSantis with 7 percent. Rubio and Representative Elise Stefanik both earned 3 percent.
Attendance at CPAC, an annual conference, tends to skew away from the political centre and farther to the right.
Speakers at this year’s conference included Senator Ted Cruz of Texas, Iranian opposition leader Reza Pahlavi, and Eduardo and Flavio Bolsonaro, the sons of Brazil’s former far-right president Jair Bolsonaro, who was imprisoned last September for attempting to subvert his country’s democracy.
But this year’s straw poll comes at a critical time for the Republican Party.
Less than eight months remain until November’s midterm elections in the US, and Republicans are hoping to defend their congressional majorities at the ballot box.
Trump, long the standard-bearer for his party, has seen his approval numbers sink since his return to office in 2025. Earlier this week, a survey from the news agency Reuters and the research firm Ipsos found that only 36 percent of US citizens approved of his job performance, a new low.
The ongoing war in Iran and economic frustrations, including rising gas prices linked to the conflict, are among the factors contributing to the slump.
While Trump has teased he may seek a third term, US law prevents modern presidents from serving more than two. His second presidency is set to expire in 2028.
That leaves an open question as to who may succeed the 79-year-old Republican.
Vance, a veteran and former single-term senator from Ohio, is seen to represent a more isolationist branch of Trump’s “Make America Great Again” (MAGA) base. He has generally been opposed to US involvement in foreign conflicts, though he has defended Trump’s decision to join Israel in joint strikes on Iran.
Rubio, meanwhile, has a longer political resume than Vance and is seen to be more hawkish towards regime change, particularly in his family’s ancestral home of Cuba. He served as a senator for Florida from 2011 until his unanimous confirmation as secretary of state in 2025.
Both men had been critical of Trump before joining his administration. Vance once called Trump “unfit” for office, and Rubio derided Trump as a “con artist” and an “embarrassment” when he was a rival candidate for the 2016 Republican presidential nomination.
CPAC tends not to survey participants about who should be president when a Republican is already in the Oval Office.
But the straw polls it held before and after Trump’s first term, from 2017 to 2021, have shown a noticeable realignment in the Republican Party.
In the decade leading up to the 2016 election – Trump’s first successful campaign for office – moderate Republican Mitt Romney and libertarian Rand Paul consistently topped the CPAC straw polls.
Ever since his first term, however, Trump has trounced the competition.
Despite his 2020 election defeat, he still topped the straw poll in 2021, with 55 percent support, and his numbers climbed each successive year, through to his re-election in 2024.
Experts have noted that the Republican Party has largely consolidated around Trump’s politics, with the few remaining moderate and critical voices increasingly marginalised.
The CPAC straw poll, however, is not always accurate. Ahead of Trump’s victory in 2016, the majority of straw poll participants backed Senator Cruz of Texas to be the next president. Trump came in third place with 15 percent support, trailing Rubio at 30 percent.
NEWYou can now listen to Fox News articles!
For women struggling with weight gain after menopause, a new study suggests that adding hormone therapy to a popular obesity drug may lead to greater weight loss.
Postmenopausal women lost about 35% more weight when using menopausal hormone therapy alongside tirzepatide — a GLP-1-based, Food and Drug Administration-approved drug for overweight and obesity — compared to those taking the drug alone, according to a Mayo Clinic study.
The findings, published in February in The Lancet Obstetrics, Gynaecology, & Women’s Health, highlight a possible new strategy for addressing weight gain after menopause, when hormonal shifts can increase the risk of obesity, cardiovascular disease and type 2 diabetes.
STOPPING OZEMPIC? NEW STUDY REVEALS SURPRISING WEIGHT REGAIN RESULTS AFTER GLP-1S
“This study provides important insights for developing more effective and personalized strategies for managing cardiometabolic risk in postmenopausal women,” Dr. Regina Castaneda, the study’s first author, said in a statement.
A new study found that postmenopausal women lost more weight when combining hormone therapy with a GLP-1-based drug. (iStock)
Researchers analyzed 120 postmenopausal women with overweight or obesity who took tirzepatide for at least 12 months, including 40 who also used hormone therapy and 80 who did not.
Hormone therapy is commonly used to treat menopause symptoms like hot flashes and night sweats, while tirzepatide helps regulate appetite and blood sugar.
WEIGHT-LOSS MEDICATIONS COULD IMPACT SEXUAL HEALTH IN UNEXPECTED WAYS
Women in the hormone therapy group lost an average of 19.2% of their body weight, compared to 14.0% in the non-hormone group — about 35% greater relative weight loss — with more women reaching significant weight-loss thresholds, according to the study.
Despite the results, researchers emphasized that the study was observational and cannot prove cause and effect.
Hormonal changes after menopause can increase weight gain and health risks. (iStock)
“Because this was not a randomized trial, we cannot say hormone therapy caused additional weight loss,” said Dr. Maria Daniela Hurtado Andrade, an endocrinologist at Mayo Clinic and senior author of the study.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Outside experts agree that the findings must be interpreted cautiously.
“As with all observational studies, we need to interpret this study with a grain of salt,” Dr. Gillian Goddard, a board-certified endocrinologist, told Fox News Digital.
Goddard, who is also an adjunct assistant professor of medicine at the NYU Grossman School of Medicine, noted that the findings show a link, but do not prove that hormone therapy, which usually includes estrogen, directly caused the additional weight loss.
CLICK HERE FOR MORE HEALTH STORIES
“There may be important differences between the two groups,” she added. “For one thing, the group taking estrogen may be healthier than the groups that didn’t take estrogen … Healthier people are more likely to eat a healthy diet and exercise in addition to taking tirzepatide. That could lead to more weight loss.”
Tirzepatide, a GLP-1-based drug, may be more effective for weight loss when paired with hormone therapy, according to researchers. (iStock)
Symptom relief from the therapy may have also improved sleep and well-being, making it easier for the group to maintain diet and exercise routines, Hurtado Andrade noted.
Researchers also pointed to a possible biological explanation. Preclinical data suggest estrogen may enhance the appetite-suppressing effects of GLP-1-based medications like tirzepatide, according to the study.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Goddard said that theory is plausible but unproven.
Hormone therapy may ease menopause symptoms and help women stay on track with diet and exercise. (iStock)
“The other possibility is that estrogen interacts with tirzepatide in some way that makes it more potent,” she said, adding, “We will need randomized studies to get a better handle on that.”
As for safety, experts say using the two together appears safe for most women. However, hormone therapy is not recommended for all patients, especially those with a history of certain cancers, blood clots or other underlying health risks, according to the Mayo Clinic.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Researchers say future randomized trials will aim to confirm the findings and explore whether the combination also improves broader cardiometabolic health outcomes, according to the study.
Experts say more research is needed to confirm whether hormone therapy directly boosts weight loss results with GLP-1 drugs. (iStock)
“If confirmed, this work could speed the development and adoption of new, evidence-based strategies to reduce this risk for millions of postmenopausal women navigating this life stage,” said Hurtado Andrade.
Fox News Digital has reached out to the study authors for comment.
NEWYou can now listen to Fox News articles!
Ukrainian President Volodymyr Zelenskyy is turning battlefield innovation into bargaining power, offering Ukraine’s anti-drone systems to Middle Eastern allies, while seeking more air-defense support as the war with Russia drags into its fourth year.
Zelenskyy met Friday in Abu Dhabi with United Arab Emirates (UAE) President Mohammed bin Zayed Al Nahyan, and the two discussed an agreement by which Ukraine would provide its cutting-edge counter-drone technology in exchange for ballistic missile support and financial aid.
In a wide-ranging interview with Fox News after the meeting, Zelenskyy detailed how Ukraine’s battlefield innovations, namely its anti-Russian drone systems, are influencing defense partnerships worldwide.
In a wide-ranging interview with Fox News, Ukrainian President Volodymyr Zelenskyy detailed how Ukraine’s battlefield innovations are influencing defense partnerships worldwide. (Fox News)
“We have, for example, drone interceptors. We have [a] system of electronic warfare and a lot of things. All these jointly work in one system. This is what we have [that] nobody has,” Zelenskyy told Fox News correspondent Matt Finn in Abu Dhabi.
Ukraine is now sharing elements of that system with at least four Persian Gulf nations — the UAE, Qatar, Jordan and Saudi Arabia — as they confront growing threats from Iran’s drone capabilities.
But Zelenskyy emphasized the partnership must be reciprocal. Ukraine continues to face a “big deficit” of critical air defense weapons, particularly PAC-3 Patriot missiles used to intercept ballistic threats.
“We are ready to help Middle East countries with our expertise and with our knowledge, and we hope … that they can help with anti-ballistic missiles,” Zelenskyy said.
Ukraine has already signed 10-year defense agreements with Saudi Arabia and Qatar, with a similar deal with the UAE expected soon, according to the AP.
TRUMP MEETS WITH ZELENSKYY; TALKS COULD UNLOCK FIRST ZELENSKYY-PUTIN CALL IN FIVE YEARS: SOURCE
A plume of smoke rises from the site of a strike in Tehran early on March 28, 2026. (Atta Kenare/AFP via Getty Images)
Zelenskyy also warned that increasing U.S. military focus on the Middle East amid escalating tensions with Iran and the ongoing “Operation Epic Fury” could slow the flow of weapons to Ukraine.
He claimed Russia is already strengthening Iran’s military by sharing drone technology, including Shahed “kamikaze” drones, as well as battlefield tactics developed during the war.
“Russia will share all they know about this war. … They’re already sharing with Iranians,” Zelenskyy said.
While he stopped short of confirming missile transfers, Zelenskyy suggested Moscow has a strategic interest in prolonging instability in the Middle East to divert U.S. attention away from Ukraine.
“This is what they do,” Zelenskyy said.
On the battlefield, Zelenskyy reiterated that Ukraine will not cede territory in the contested Donbas region, arguing it would weaken defenses, damage troop morale and displace tens of thousands of civilians.
“I think their morale will decrease,” Zelenskyy said.
He also urged the Trump administration not to lose sight of Ukraine while addressing Middle East tensions.
AS UKRAINE WAR DRAGS ON, TRUMP HITS PUTIN BY SQUEEZING RUSSIA’S PROXIES
Destroyed homes after a Russian drone attack March 28 in Odesa, Ukraine. (Viacheslav Onyshchenko/Global Images Ukraine via Getty Images)
More than 270 Russian drones struck Ukraine overnight Friday, leaving at least five people dead, Ukrainian officials said Saturday, according to AP.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“I hope that President Trump … will find a way to end this war with pressure on the Iranian regime, and I hope that also they will not forget about … the war of Russia against Ukraine,” Zelenskyy said.
The Associated Press contributed to this report.
Global landmarks including the Eiffel Tower in Paris and Sagrada Família Basilica in Barcelona switched off their lights for an hour at 20:30 local time on Saturday night to mark Earth Hour.
The global event, organised by the World Wide Fund for Nature, takes place every year to raise environmental awareness.
It aims to encourage people to turn off their lights for 60 minutes and the event first started in Sydney, Australia, in 2007.
Video journalist: Emaan Warraich
Loughborough Lightning extended their 100% start to the Netball Super League season with an 83-69 victory against bottom side Birmingham Panthers.
Samantha Wallace-Joseph scored 35 goals for Lightning, who have won their first five matches to establish a three-point lead at the top of the table.
“It can be hard [being unbeaten] because all the teams are coming for us,” the Trinidad and Tobago goal shooter told BBC Sport.
“It’s just about keeping our consistency going, gelling together and executing the game plan.”
Panthers have lost their first five league matches of the campaign, each by a margin of at least 10, but they put up their biggest tally of goals in a match this season in a performance that pleased head coach Sonia Mkoloma.
“It wasn’t just the biggest score – I thought we stayed in it for longer,” Mkoloma told BBC Sport.
“We were competitive across four quarters, which we haven’t been, so I’m proud of them. I asked them to be competitive in this game and they stayed in it.”
NEWYou can now listen to Fox News articles!
UConn women’s basketball head coach Geno Auriemma put the NCAA on blast.
The 72-year-old coach took umbrage with the NCAA for not consulting the players or coaches before making changes to the tournament’s format.
The NCAA shifted from a four-site regional to a two-site regional in 2023, which Auriemma said has created issues for shootaround times and quality of play.
“I just don’t understand some of the decisions that are made about our game when we’re trying to grow the god—- game,” Auriemma said at a press conference Saturday.
CLICK HERE FOR MORE SPORTS COVERAGE ON FOXNEWS.COM
UConn head coach Geno Auriemma watches a play late in the second half of a Sweet 16 game of the NCAA Tournament against North Carolina in Fort Worth, Texas, March 27, 2026. (LM Otero/AP Photo)
“Does anybody who makes these decisions ever ask the coaches and the players, ‘Hey, does this work? Do you guys do this during the regular season? Is this normal?'”
Auriemma opened his news conference by listing some of the dismal 3-point shooting numbers from teams in Friday’s Sweet 16 games: 4 for 20 (UConn), 4 for 22 (North Carolina), 1 for 17 (Notre Dame), 5 for 18 (Vanderbilt), 4 for 16 (UCLA) and 7 for 26 (Duke).
The legendary coach lamented the timing and duration of UConn’s shootaround.
“Know what time our shootaround was yesterday?” Auriemma said. “Six twenty (a.m. ET), I think, for half an hour. This morning, I just saw Notre Dame leaving, so they had media this morning. Their practice time is tonight at 5:30. … You know what time our practice time is? 6:30 tonight.”
UConn head coach Geno Auriemma reacts to a play during the first half of a Sweet 16 game of the NCAA Tournament against North Carolina in Fort Worth, Texas, on March 27, 2026. (Julio Cortez/AP Photo)
With eight teams sharing an arena, there is less practice time to go around for each team. Auriemma also suggested the equipment being used is causing a decrease in the quality of play.
“I think they bring in new baskets, new basketballs right out of the box,” Auriemma said.
“Got people dribbling the ball off their feet. You got people missing layups all over the place. You bounce the ball, and it goes up to the ceiling. There’s just no concept of how basketball is played.”
The 12-time national championship-winning head coach said maybe the teams had a bad shooting day, but all of their shooting numbers were well below what their averages were throughout the season.
“How many arenas are we going to sell out with that bulls—?” Auriemma said.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
UConn head coach Geno Auriemma reacts to a play during the first half of a Sweet 16 game of the NCAA Tournament against North Carolina in Fort Worth, Texas, March 27, 2026. (Julio Cortez/AP Photo)
The NCAA’s intention of switching to a two-regional format was to drive attendance, and it told ESPN it has drawn the highest numbers in tournament history since implemented. Lynn Holzman, the NCAA’s vice president for women’s basketball, told ESPN the positives outweigh the negatives.
Auriemma said he does not have any answers for the right solution, just questions.
The esteemed head coach will look to lead his top-seeded, undefeated squad (37-0) to a victory in the Elite 8 against No. 6 Notre Dame Sunday at 1 p.m. ET.
Follow Fox News Digital’s sports coverage on X, and subscribe to the Fox News Sports Huddle newsletter.
